PureTech Health plc

Transaction in Own Shares • Dec 27, 2023

National Storage Mechanism | Additional information

RNS Number : 8395X

PureTech Health PLC

27 December 2023

27 December 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase:	22 December 2023
Number of ordinary shares purchased:	35,715
Highest price paid per share:	158.60p
Lowest price paid per share:	150.80p
Volume weighted average price paid per share:	152.90p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 17,614,428 ordinary shares in treasury and has 271,853,731 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 271,853,731 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

Transaction Date	Transaction Time	Volume	Price (GBp)	Platform	Transaction Reference Number
22/12/2023	08:13:02	279	151.8	CHIX	00383501662TRLO0.1.1
22/12/2023	08:13:02	32	152	CHIX	00383501663TRLO0.1.1
22/12/2023	08:15:39	279	151.8	CHIX	00383501962TRLO0.1.1
22/12/2023	08:15:39	20	152	CHIX	00383501963TRLO0.1.1
22/12/2023	08:17:59	279	151.8	CHIX	00383502239TRLO0.1.1
22/12/2023	08:18:01	208	151.8	BATE	00383502244TRLO0.1.1
22/12/2023	08:42:06	1016	152	XLON	00383505327TRLO0.1.1
22/12/2023	08:42:06	700	152	XLON	00383505328TRLO0.1.1
22/12/2023	08:42:06	66	152	XLON	00383505329TRLO0.1.1
22/12/2023	08:42:09	41	151.4	XLON	00383505336TRLO0.1.1
22/12/2023	08:42:12	25	151.4	XLON	00383505340TRLO0.1.1
22/12/2023	08:42:12	2194	151.4	XLON	00383505341TRLO0.1.1
22/12/2023	08:42:14	279	152	AQXE	00383505343TRLO0.1.1
22/12/2023	08:49:01	29	152	AQXE	00383506262TRLO0.1.1
22/12/2023	08:49:54	279	152	AQXE	00383506365TRLO0.1.1
22/12/2023	08:55:41	372	151.4	AQXE	00383507218TRLO0.1.1
22/12/2023	08:55:41	96	151.2	BATE	00383507219TRLO0.1.1
22/12/2023	08:55:41	893	151.4	CHIX	00383507220TRLO0.1.1
22/12/2023	08:55:41	144	151.2	BATE	00383507221TRLO0.1.1
22/12/2023	08:55:41	217	151.2	BATE	00383507222TRLO0.1.1
22/12/2023	08:55:41	412	151.2	BATE	00383507223TRLO0.1.1
22/12/2023	08:55:41	261	151.2	BATE	00383507224TRLO0.1.1
22/12/2023	08:55:41	237	151.4	CHIX	00383507225TRLO0.1.1
22/12/2023	08:55:41	1813	151	XLON	00383507226TRLO0.1.1
22/12/2023	08:55:41	52	151.4	TRQX	00383507227TRLO0.1.1
22/12/2023	08:55:41	447	151	XLON	00383507229TRLO0.1.1
22/12/2023	08:55:41	142	151.4	TRQX	00383507228TRLO0.1.1
22/12/2023	08:55:41	142	151.4	TRQX	00383507230TRLO0.1.1
22/12/2023	08:55:41	52	151.4	TRQX	00383507231TRLO0.1.1
22/12/2023	08:55:47	279	151	CHIX	00383507247TRLO0.1.1
22/12/2023	09:07:47	1148	150.8	CHIX	00383509008TRLO0.1.1
22/12/2023	09:07:47	84	151	CHIX	00383509009TRLO0.1.1
22/12/2023	09:13:32	990	151.8	CHIX	00383509915TRLO0.1.1
22/12/2023	09:13:32	194	151.8	TRQX	00383509917TRLO0.1.1
22/12/2023	09:13:32	1695	151.8	XLON	00383509916TRLO0.1.1
22/12/2023	09:47:30	57	153.2	BATE	00383514659TRLO0.1.1
22/12/2023	09:49:22	372	152.2	AQXE	00383515070TRLO0.1.1
22/12/2023	09:49:22	865	152.2	BATE	00383515071TRLO0.1.1
22/12/2023	09:49:22	1130	152.2	CHIX	00383515072TRLO0.1.1
22/12/2023	09:49:22	1695	152.2	XLON	00383515073TRLO0.1.1
22/12/2023	09:49:22	194	152.2	TRQX	00383515074TRLO0.1.1
22/12/2023	10:41:15	140	151.4	BATE	00383521458TRLO0.1.1
22/12/2023	10:54:43	48	152.6	AQXE	00383524055TRLO0.1.1
22/12/2023	10:54:43	68	152.6	AQXE	00383524056TRLO0.1.1
22/12/2023	10:55:17	279	152.6	AQXE	00383524175TRLO0.1.1
22/12/2023	11:00:35	565	151.6	BATE	00383525058TRLO0.1.1
22/12/2023	11:00:35	785	151.6	AQXE	00383525057TRLO0.1.1
22/12/2023	11:00:35	1130	151.6	CHIX	00383525059TRLO0.1.1
22/12/2023	11:00:35	2260	151.6	XLON	00383525060TRLO0.1.1
22/12/2023	11:00:35	194	151.6	TRQX	00383525061TRLO0.1.1
22/12/2023	11:04:59	1130	151.8	CHIX	00383525860TRLO0.1.1
22/12/2023	11:08:55	464	151.8	CHIX	00383526673TRLO0.1.1
22/12/2023	11:36:23	869	153.6	XLON	00383530857TRLO0.1.1
22/12/2023	11:36:23	710	153.6	XLON	00383530858TRLO0.1.1
22/12/2023	11:36:26	412	153.6	XLON	00383530877TRLO0.1.1
22/12/2023	11:36:34	482	153.6	XLON	00383530899TRLO0.1.1
22/12/2023	11:36:38	259	153.6	XLON	00383530905TRLO0.1.1
22/12/2023	11:36:42	330	153.6	XLON	00383530912TRLO0.1.1
22/12/2023	11:36:58	71	154.2	CHIX	00383531014TRLO0.1.1
22/12/2023	11:37:31	990	158.6	BATE	00383531075TRLO0.1.1
22/12/2023	11:37:51	440	158.2	CHIX	00383531113TRLO0.1.1
22/12/2023	11:37:51	250	158.2	CHIX	00383531114TRLO0.1.1
22/12/2023	11:37:51	586	158.2	XLON	00383531116TRLO0.1.1
22/12/2023	11:37:51	3173	158.2	XLON	00383531115TRLO0.1.1
22/12/2023	11:37:51	371	158.2	XLON	00383531117TRLO0.1.1
21/12/2023	16:29:51	64	150.6	XLON	00383452416TRLO0.1.1
21/12/2023	16:29:55	153	150.6	TRQX	00383452507TRLO0.1.1
21/12/2023	16:29:55	329	150.6	XLON	00383452508TRLO0.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFVDFLLFFIV